Fig. 8From: A randomized, double-blind, placebo-controlled investigation of BCc1 nanomedicine effect on survival and quality of life in metastatic and non-metastatic gastric cancer patientsa Kaplan–Meier diagram of survival. b Hazard function diagram in non-metastatic patients who only received interventions (BCc1nanomedicine or placebo) without undergoing chemotherapyBack to article page